These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19394937)

  • 1. Pro-atherogenic effects of probucol in apo E-KO mice may be mediated through alterations in immune system: Parallel alterations in gene expression in the aorta and liver.
    Xu Z; Azordegan N; Zhao Z; Le K; Othman RA; Moghadasian MH
    Atherosclerosis; 2009 Oct; 206(2):427-33. PubMed ID: 19394937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary phytosterols reduce probucol-induced atherogenesis in apo E-KO mice.
    Moghadasian MH
    Atherosclerosis; 2006 Sep; 188(1):28-34. PubMed ID: 16325824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice.
    Tous M; Ferré N; Rull A; Marsillach J; Coll B; Alonso-Villaverde C; Camps J; Joven J
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1078-84. PubMed ID: 16403442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice.
    Boué S; Tarasov K; Jänis M; Lebrun S; Hurme R; Schlage W; Lietz M; Vuillaume G; Ekroos K; Steffen Y; Peitsch MC; Laaksonen R; Hoeng J
    Atherosclerosis; 2012 Dec; 225(2):328-34. PubMed ID: 23102783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action.
    Moghadasian MH; McManus BM; Godin DV; Rodrigues B; Frohlich JJ
    Circulation; 1999 Apr; 99(13):1733-9. PubMed ID: 10190884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans.
    Moghadasian MH; McManus BM; Nguyen LB; Shefer S; Nadji M; Godin DV; Green TJ; Hill J; Yang Y; Scudamore CH; Frohlich JJ
    FASEB J; 2001 Dec; 15(14):2623-30. PubMed ID: 11726538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic synthesis of phytosteryl docosahexaneates and evaluation of their anti-atherogenic effects in apo-E deficient mice.
    Tan Z; Le K; Moghadasian M; Shahidi F
    Food Chem; 2012 Oct; 134(4):2097-104. PubMed ID: 23442661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice.
    Choy K; Beck K; Png FY; Wu BJ; Leichtweis SB; Thomas SR; Hou JY; Croft KD; Mori TA; Stocker R
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1684-90. PubMed ID: 15961704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
    Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice.
    Naoum JJ; Woodside KJ; Zhang S; Rychahou PG; Hunter GC
    Transplant Proc; 2005 May; 37(4):1880-4. PubMed ID: 15919492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
    Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
    Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice.
    Xiao N; Yin M; Zhang L; Qu X; Du H; Sun X; Mao L; Ren G; Zhang C; Geng Y; An L; Pan J
    Mol Genet Metab; 2009 Apr; 96(4):239-44. PubMed ID: 19157944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term phytosterol treatment alters gene expression in the liver of apo E-deficient mice.
    Xu Z; Le K; Moghadasian MH
    J Nutr Biochem; 2008 Aug; 19(8):545-554. PubMed ID: 18155511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
    Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
    Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice.
    Moos MP; John N; Gräbner R; Nossmann S; Günther B; Vollandt R; Funk CD; Kaiser B; Habenicht AJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2386-91. PubMed ID: 16179593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.